General Information of This Metabolic Reaction (MR) (ID:
MR006916) |
Formula |
|
Reactant |
Losartan potassium |
Product |
Losartan carboxylic acid |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 3A4 (CYP3A4)
|
DME Info
|
Cytochrome P450 2C9 (CYP2C9)
|
DME Info
|
Cytochrome P450 3A5 (CYP3A5)
|
DME Info
|
Metabolic Type
|
Oxidation
-
N-oxidation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Produce The Product of This MR
|
|
References |
1 |
Clinical pharmacokinetics of losartan. Clin Pharmacokinet. 2005;44(8):797-814.
|
2 |
Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.